These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33402016)

  • 1. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
    Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
    J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
    Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
    Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
    Caldwell L; Bhakta R; Naik N; Knowles BD; Parker J; Van Berkel Patel M
    J Pharm Pract; 2024 Oct; 37(5):1149-1156. PubMed ID: 38261533
    [No Abstract]   [Full Text] [Related]  

  • 4. Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
    Hayes K; Fernando MC; Jordan V
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013551. PubMed ID: 36408876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
    Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
    World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
    DeLoughery E; Avery B; DeLoughery TG
    Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients.
    Faraoni D; Guindi A; Ankola AA; Resheidat A; Binsalamah Z; Teruya J; Savorgnan F; Vener DF
    J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):388-393. PubMed ID: 38129208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
    Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
    McCall P; Story DA; Karalapillai D
    Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury.
    Joseph B; Hadjizacharia P; Aziz H; Kulvatunyou N; Tang A; Pandit V; Wynne J; O'Keeffe T; Friese RS; Rhee P
    J Trauma Acute Care Surg; 2013 Jan; 74(1):248-53. PubMed ID: 23271101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 4-Factor Prothrombin Complex Concentrate With Frozen Plasma for Management of Hemorrhage During and After Cardiac Surgery: A Randomized Pilot Trial.
    Karkouti K; Bartoszko J; Grewal D; Bingley C; Armali C; Carroll J; Hucke HP; Kron A; McCluskey SA; Rao V; Callum J
    JAMA Netw Open; 2021 Apr; 4(4):e213936. PubMed ID: 33792729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion.
    Ho KM; Litton E
    Transfusion; 2012 Aug; 52(8):1696-702. PubMed ID: 22211634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.